The average sodium intake worldwide is estimated at 4,310 mg/day (10.78 g salt per day), which is significantly higher than physiological needs (500 mg/day) and more than double the World Health Organization (WHO) recommends (2,000 mg/day) [
1]. Non-communicable diseases (NCDs) are the leading cause of death worldwide, responsible for 41.5 million deaths in 2016 (71% of the 57 million deaths), more than all the other causes combined [
2]. Cardiovascular diseases (CVDs) account for most deaths and raised blood pressure (BP) is the leading risk factor for CVDs. The recent Global Burden of Disease Study (GBDS) showed that high BP accounted for 10.4 million deaths and 218 million disability-adjusted life years (DALYs) in 2017 [
3]. According to the meta-analysis, the number of people with arterial hypertension (AH) doubled between 1990 and 2019 and currently is approximately 1.3 billion [
4]. Even a small increase in BP is associated with an increase in CV risk, including stroke, myocardial infarction, coronary heart disease and heart failure [
5]. The WHO 2023 Global report on AH stated that elevated BP is one of the most important risk factors for disability and death worldwide [
6]. High salt intake which is a well-established cause of high BP was responsible for 3.2 million deaths and 70 million DALYs [
7,
8,
9,
10,
11,
12,
13]. According to the GBDS from 2019, the number of deaths from CVDs associated with high salt intake is 41.08% higher than it was in 1990 [
14]. A reduction of 100 mmol/day in 24-hour urinary sodium excretion is associated with systolic BP reduction of 5.56 mmHg [
15]. While the primary health effect associated with a diet high in sodium is raised BP, there is a growing body of evidence documenting the impact of high sodium intake on various health outcomes, including gastric cancer [
16,
17], obesity [
18,
19,
20,
21,
22] osteoporosis [
23] etc. Based on the analysis of the GBDS data, it was concluded that the total number of deaths from chronic kidney disease (CKD) associated with increased salt intake was 45,530, while the number of DALYs was 1.32 million [
24]. In a prospective study, we found that in our population with low potassium intake, increased salt intake is a significant risk factor for new-onset CKD [
25]. A 2021 Cochrane review concluded that reducing high salt intake in patients in the early stages of CKD and with albuminuria is associated with a reduction in BP, which may lead to a slowing of CKD progression and a reduction in CV risk [
26]. Recently published research has confirmed that high salt intake increases the risk of type 2 diabetes [
27], and a Cochrane review published in 2023 concluded that reducing salt intake in patients with diabetes can significantly lower BP, preventing the onset and slowing the progression of diabetic kidney disease and that salt intake in patients with diabetes, whether or not they have AH and whether or not they already have signs of CKD, must be less than 5 g per day (less than 2 g of sodium) [
28]. In 2013, the WHO recommended to all Member States to reduce population salt intake by 30%, as a part of the 9 global targets to reduce premature mortality from NCDs by 25% by 2025 [
29]. Reducing salt intake in populations is among the most cost-effective interventions to reduce the burden of NCDs and is therefore considered a priority action for all countries (an average cost-effectiveness ratio of ≤ I
$100/DALY averted in low- and lower middle-income countries) [
30,
31,
32,
33]. The Sodium Country Score Card was established as part of a WHO's efforts primarily to reduce dietary sodium intake, but this system will continuously monitor countries' performance and continue to be enhanced with additional features [
34,
35]. In 2016, the WHO published the SHAKE Technical Package for Salt Reduction, to further stimulate Member States in carrying out salt reduction strategies through 5 key action areas: surveillance, harnessing industry, adopting standards for labeling, knowledge, and environment [
36]. In 2017, WHO recommended several sodium-related best buys policies and other measures as practical actions that should be undertaken immediately, to prevent CVD [
37]. In 2023, WHO launched the first Global Report on Sodium Intake Reduction investigating the progress of countries which are implementing sodium reduction policies and their impact on population and CVD [
38]. Finally, salt reduction recommendation is an essential part of all relevant guidelines [
39,
40,
41,
42,
43].
Since it is obvious that the primary goal of decreasing salt consumption for 30% by 2025 will not be achieved WHO called for accelerated actions in scaling up efforts to reduce populations’ sodium intake.